| Literature DB >> 35978740 |
Catarina Mateus1, Ana Rita Martins1, Cristina Toscano2, Patrícia Matias1, Patrícia Branco1.
Abstract
Peritonitis is the most common complication of peritoneal dialysis (PD) and an important cause of PD failure. There are numerous etiological agents, mostly bacteria. Pantoea spp is a rare cause of peritonitis. We describe three cases of Pantoea peritonitis in three PD patients. Previous reports have identified risk factors such as close contact with plants and animals. We review the typical clinical presentation and prognosis. It is fulcral to teach patients about the risks regarding proximity to plants and animals to prevent this type of infection.Entities:
Keywords: erwinia; pantoea; pantoea agglomerans; peritoneal dialysis; peritonitis
Year: 2022 PMID: 35978740 PMCID: PMC9375850 DOI: 10.7759/cureus.26878
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Summary of Pantoea PD peritonitis in our clinical cases
ESKD, end-stage kidney disease; TNCC, total nucleated cell count; HT, hypertension; IP, intraperitoneal; IV, intravenous; PD, peritoneal dialysis
| Clinical case, sex, age | ESKD cause | Dialysis vintage months | Epidemiological context | Effluent TNCC (/mm3)/neutrophils (%) | Microbiological agent | Antibiotic used/route |
| Case I, male, 63 | Horseshoe kidney, calcium oxalate calculi, and HT | 12 | Gardening one week before. Abrasive wounds in the forearms | 6,720/74 | P. agglomerans | Ceftazidime and ciprofloxacin/IP |
| Case II, female, 64 | Goodpasture syndrome | 15 | Hobby: gardening | 1,485/85 | Pantoea spp and Staphylococcus aureus | Vancomycin, gentamicin, and ciprofloxacin/IV |
| Case III, female, 45 | Unknown etiology | 1 | PD helper was a gardener | 1,600/78 | Pantoea spp and Leclercia adecarboxylata | Cefazoline and ceftazidime/IV |
Cases of Pantoea spp PD peritonitis described in the literature
DM, diabetes; ESKD, end-stage kidney disease; PD, peritoneal dialysis; TNCC, total nucleated cell count; ST, successful treatment; HT, hypertension; IP, intraperitoneal; IV, intravenous; M, male; F, female; NA, not available; CAPD, continuous ambulatory peritoneal dialysis; APD, automated peritoneal dialysis
| Case | Sex/age | ESKD cause | PD prescription/dialysis vintage (years) | Epidemiological context | Effluent TNCC (/mm3)/neutrophils (%) | Microbiological agent | Antibiotic used/route | Outcome |
| Lau et al. 2005 [ | F/2 | NA | NA | Teething on the catheter | NA | P. agglomerans | Cefotaxime and gentamicin/IP | ST and PD catheters replaced |
| Lim et al. 2006 [ | M/49 | Focal segmental glomerulosclerosis | CAPD/5 | Rose-thorn injury | 3,600/85 | P. agglomerans | Ceftazidime and amikacin/IP | ST |
| Magnette et al. 2008 [ | F/65 | Left nephrectomy because of congenital hydronephrosis, HT, and DM | NA/2 | Translocation from the GI tract | 2,800/88 | P. agglomerans | Cefazolin/IP and Ciprofloxacin/IV | ST |
| Ferrantino et al. 2008 [ | M/51 | NA | NA | Gardening 5 days before | 3,600/74 | P. agglomerans | Cefepime/IP | ST |
| Habhab and Blake 2008 [ | F/52 | Obstructive uropathy | NA | Close contact with a dog | 10.8x109/85 | P. agglomerans | Ciprofloxacin/oral | ST |
| Borràs et al. 2009 [ | F/56 | Myeloma cast nephropathy and HT | CAPD/5 | NA | 320/88 | P. agglomerans | Tobramycin and vancomycin/IV | ST |
| Kahveci et al. 2011 [ | F/87 | DM | APD/10 | NA | 3,400/NA | P. agglomerans | Sefuroksin and ciprofloxacin/IP. Later, imipenem/IV | Dead (septic shock) Patient refused PD catheter removal |
| Kazancioglu et al. 2014 [ | F/63 | HT | NA/1 | Previous contact of the catheter with nonsterile surfaces | 810/NA | P. agglomerans | Cefazolin and gentamicin/IP | ST |
| Chen et al. 2013 [ | F/58 | DM | NA/8 | NA | 2,190/NA | Citrobacter youngae and P. agglomerans | Levofloxacin/IV | ST |
| Choi et al. 2012 [ | M/52 | HT, liver cirrhosis | CAPD/NA | Diarrhea and episode of peritonitis 5 weeks before | 5,940/91 | P. agglomerans | Cefazolin and gentamicin/IP | ST |
| Sastre et al. 2017 [ | M/83 | Nephroangiosclerosis | CAPD/4 | NA | 560/µL/80 | P. agglomerans | Cefazolin and tobramycin/IP | ST |